F/ List of principal companies included in the consolidation during 2017
F.1. Principal fully consolidated companies
The table below shows the principal companies and their country of incorporation:
| Europe |
Financial interest (%) as of December 31, 2017 |
|||
| Hoechst GmbH | Germany | 100.0 | ||
| Zentiva Pharma GmbH | Germany | 100.0 | ||
| Zentiva Inhalationsprodukte GmbH | Germany | 100.0 | ||
| Sanofi-Aventis Deutschland GmbH | Germany | 100.0 | ||
| Aventis Beteiligungsverwaltung GmbH | Germany | 100.0 | ||
| Genzyme GmbH | Germany | 100.0 | ||
| Sanofi-Aventis GmbH | Austria | 100.0 | ||
| Sanofi Belgium | Belgium | 100.0 | ||
| Sanofi European Treasury Center | Belgium | 100.0 | ||
| Genzyme Flanders BVBA | Belgium | 100.0 | ||
| Sanofi-Aventis Denmark A/S | Denmark | 100.0 | ||
| Sanofi-Aventis SA | Spain | 100.0 | ||
| Sanofi Oy | Finland | 100.0 | ||
| Sanofi | France | 100.0 | ||
| Sanofi-Aventis France | France | 100.0 | ||
| Sanofi Winthrop Industries | France | 100.0 | ||
| Sanofi-Aventis Recherche et Développement | France | 100.0 | ||
| Sanofi-Aventis Groupe | France | 100.0 | ||
| Sanofi CLIR | France | 50.1 | ||
| Sanofi Chimie | France | 100.0 | ||
| Francopia | France | 100.0 | ||
| Sanofi-Aventis Europe SAS | France | 100.0 | ||
| Sanofi-Aventis Participations SAS | France | 100.0 | ||
| Genzyme SAS | France | 100.0 | ||
| Genzyme Polyclonals SAS | France | 100.0 | ||
| Sanofi Pasteur (France) SA | France | 100.0 | ||
| Aventis Pharma SA (France) | France | 100.0 | ||
| Sanofi-Aventis Am Nord SAS | France | 100.0 | ||
| Zentiva France | France | 100.0 | ||
| Aventis Agriculture | France | 100.0 | ||
| Biopark By Sanofi | France | 100.0 | ||
| Chattem Greece S.A. | Greece | 100.0 | ||
| Sanofi-Aventis A.E.B.E | Greece | 100.0 | ||
| Sanofi-Aventis Private Co, Ltd | Hungary | 99.6 | ||
| Chinoin Private Co. Ltd | Hungary | 99.6 | ||
| Carraig Insurance DAC | Ireland | 100.0 | ||
| Sanofi-Aventis Ireland Ltd | Ireland | 100.0 | ||
| Europe |
Financial interest (%) as of December 31, 2017 |
|||
| Genzyme Ireland Limited | Ireland | 100.0 | ||
| Sanofi Spa | Italy | 100.0 | ||
| Genzyme Global Sarl | Luxembourg | 100.0 | ||
| Sanofi-Aventis Norge AS | Norway | 100.0 | ||
| Sanofi-Aventis Netherlands B.V. | Netherlands | 100.0 | ||
| Genzyme Europe BV | Netherlands | 100.0 | ||
| Sanofi-Aventis Sp. z.o.o. | Poland | 100.0 | ||
| Winthrop Farmaceutica Portugal Lda | Portugal | 100.0 | ||
| Sanofi Produtos Farmaceuticos Lda | Portugal | 100.0 | ||
| Zentiva, k.s. | Czech Republic | 100.0 | ||
| Zentiva Group, a.s. | Czech Republic | 100.0 | ||
| Sanofi-Aventis, s.r.o. | Czech Republic | 100.0 | ||
| Sanofi-Aventis Romania SRL | Romania | 100.0 | ||
| Sanofi-Synthelabo Ltd | United Kingdom | 100.0 | ||
| Sanofi Pasteur Holding Limited | United Kingdom | 100.0 | ||
| Chattem Limited (UK) | United Kingdom | 100.0 | ||
| Sanofi-Aventis UK Holdings Limited | United Kingdom | 100.0 | ||
| Genzyme Limited | United Kingdom | 100.0 | ||
| May and Baker Limited | United Kingdom | 100.0 | ||
| Aventis Pharma Limited | United Kingdom | 100.0 | ||
| Fisons Limited | United Kingdom | 100.0 | ||
| Limited Liability Zentiva Pharma | Russia | 100.0 | ||
| Sanofi-Aventis Vostok | Russia | 100.0 | ||
| AO Sanofi Russia | Russia | 100.0 | ||
| Zentiva a.s. | Slovakia | 98.9 | ||
| Sanofi-Aventis Pharma Slovakia s.r.o. | Slovakia | 100.0 | ||
| Sanofi AB | Sweden | 100.0 | ||
| Sanofi SA (Sanofi AG) | Switzerland | 100.0 | ||
| Sanofi-Aventis (Suisse) SA | Switzerland | 100.0 | ||
| Pharmaton | Switzerland | 100.0 | ||
| Zentiva Saglik Urunleri Sanayi ve Ticaret A.S. | Turkey | 100.0 | ||
| Sanofi-Aventis Ilaclari Limited Sirketi | Turkey | 100.0 | ||
| Sanofi Pasteur Asi Ticaret A.S. | Turkey | 100.0 | ||
| Sanofi-Aventis Ukraine | Ukraine | 100.0 | ||
| United States |
Financial interest (%) as of December 31, 2017 |
|||
| Sanofi US Services Inc | United States | 100.0 | ||
| Sanofi-Aventis US LLC | United States | 100.0 | ||
| Sanofi Pasteur Biologics, LLC | United States | 100.0 | ||
| Chattem, Inc. | United States | 100.0 | ||
| United States |
Financial interest (%) as of December 31, 2017 |
|||
| Sanofi Pasteur VaxDesign Corporation | United States | 100.0 | ||
| Carderm Capital L.P. | United States | 100.0 | ||
| Aventisub LLC | United States | 100.0 | ||
| Genzyme Corporation | United States | 100.0 | ||
| Armour Pharmaceutical Company | United States | 100.0 | ||
| Sanofi Pasteur Inc. | United States | 100.0 | ||
| Protein Sciences Corporation | United States | 100.0 | ||
| Aventis Inc. | United States | 100.0 | ||
| VaxServe, Inc. | United States | 100.0 | ||
| Other Countries | Financial interest (%) as of December 31, 2017 |
|||
| Sanofi-Aventis South Africa (Pty) Ltd | South Africa | 100.0 | ||
| Zentiva South Africa (Pty) Ltd | South Africa | 100.0 | ||
| Sanofi-Aventis Algérie | Algeria | 100.0 | ||
| Winthrop Pharma Saidal SPA | Algeria | 70.0 | ||
| Sanofi-Aventis Argentina S.A. | Argentina | 100.0 | ||
| Genzyme de Argentina SA | Argentina | 100.0 | ||
| Sanofi-Aventis Healthcare Pty Ltd | Australia | 100.0 | ||
| Sanofi-Aventis Australia Pty Ltd | Australia | 100.0 | ||
| Medley Farmaceutica Ltda | Brazil | 100.0 | ||
| Sanofi-Aventis Farmaceutica Ltda | Brazil | 100.0 | ||
| Sanofi-Aventis Canada Inc. | Canada | 100.0 | ||
| Sanofi Consumer Health Inc | Canada | 100.0 | ||
| Sanofi Pasteur Limited (Canada) | Canada | 100.0 | ||
| Sanofi-Aventis de Chile SA | Chile | 100.0 | ||
| Sanofi (Hangzhou) Pharmaceuticals Co., Ltd | China | 100.0 | ||
| Sanofi (China) Investment Co., Ltd | China | 100.0 | ||
| Sanofi Beijing Pharmaceuticals Co.Ltd | China | 100.0 | ||
| Shenzhen Sanofi pasteur Biological Products Co, Ltd | China | 100.0 | ||
| Winthrop Pharmaceuticals de Colombia SA | Colombia | 100.0 | ||
| Genfar S.A. | Colombia | 100.0 | ||
| Sanofi-Aventis de Colombia S.A. | Colombia | 100.0 | ||
| Sanofi-Aventis Korea Co. Ltd | South Korea | 100.0 | ||
| Genzyme Korea Co Ltd | South Korea | 100.0 | ||
| Sanofi-Aventis Gulf FZE | United Arab Emirates | 100.0 | ||
| Sanofi-Aventis del Ecuador S.A. | Ecuador | 100.0 | ||
| Sanofi Egypt S.A.E | Egypt | 99.8 | ||
| Sanofi-Aventis de Guatemala S.A. | Guatemala | 100.0 | ||
| Sunstone China Limited | Hong Kong | 100.0 | ||
| Sanofi-Aventis Hong-Kong Limited | Hong Kong | 100.0 | ||
| Sanofi-Synthelabo (India) Private Ltd | India | 100.0 | ||
| Sanofi India Limited | India | 60.4 | ||
| Other Countries | Financial interest (%) as of December 31, 2017 |
|||
| Shantha Biotechnics Private Ltd | India | 98.7 | ||
| PT Aventis Pharma | Indonesia | 80.0 | ||
| Sanofi-Aventis Israël Ltd | Israel | 100.0 | ||
| Sanofi K.K. | Japan | 100.0 | ||
| SSP Co., Ltd | Japan | 100.0 | ||
| Winthrop Pharmaceuticals (Malaysia) SDN. BHD. | Malaysia | 100.0 | ||
| Sanofi-Aventis (Malaysia) SDN. BHD. | Malaysia | 100.0 | ||
| Sanofi-Aventis Maroc | Morocco | 100.0 | ||
| Sanofi-Aventis de Mexico S.A de CV | Mexico | 100.0 | ||
| Sanofi-Aventis Winthrop SA de CV | Mexico | 100.0 | ||
| Sanofi Pasteur SA de CV | Mexico | 100.0 | ||
| Sanofi-Aventis Pakistan Ltd | Pakistan | 52.9 | ||
| Sanofi-Aventis de Panama S.A. | Panama | 100.0 | ||
| Sanofi-Aventis Latin America SA | Panama | 100.0 | ||
| Sanofi-Aventis del Peru SA | Peru | 100.0 | ||
| Genfar Peru S.A. | Peru | 100.0 | ||
| Sanofi-Aventis Philippines Inc | Philippines | 100.0 | ||
| Sanofi-Aventis de la Republica Dominicana S.A. | Dominican Republic | 100.0 | ||
| Sanofi-Aventis Singapore Pte Ltd | Singapore | 100.0 | ||
| Aventis Pharma (Manufacturing) PTE LTD | Singapore | 100.0 | ||
| Sanofi Taiwan Co Ltd | Taiwan | 100.0 | ||
| Zentiva (Thailand) limited | Thailand | 100.0 | ||
| Sanofi-Aventis Thailand Ltd | Thailand | 100.0 | ||
| Sanofi-Aventis Pharma Tunisie | Tunisia | 100.0 | ||
| Winthrop Pharma Tunisie | Tunisia | 100.0 | ||
| Sanofi-Aventis de Venezuela SA | Venezuela | 100.0 | ||
| Sanofi-Synthelabo Vietnam | Vietnam | 70.0 | ||
| Sanofi Vietnam Shareholding Company | Vietnam | 100.0 | ||
F.2. Principal investments accounted for using the equity method
| Financial interest (%) as of December 31, 2017 |
||||
| Infraserv GmbH & Co. Höchst KG | Germany | 31.2 | ||
| Bristol-Myers Squibb / Sanofi Canada Partnership | Canada | 49.9 | ||
| China Resources Sanjiu Sanofi Consumer Healthcare Ltd | China | 30.0 | ||
| Bristol-Myers Squibb / Sanofi Pharmaceuticals Holding Partnership | United States | 49.9 | ||
| Bristol-Myers Squibb / Sanofi Pharmaceuticals Partnership | United States | 49.9 | ||
| Bristol-Myers Squibb / Sanofi Pharmaceuticals Partnership Puerto Rico | United States | 49.9 | ||
| Bristol-Myers Squibb / Sanofi-Synthélabo Partnership | United States | 49.9 | ||
| Bristol-Myers Squibb / Sanofi-Synthélabo Puerto Rico Partnership | United States | 49.9 | ||
| Regeneron Pharmaceuticals, Inc. | United States | 22.2 | ||
| Onduo LLC | United States | 50.0 | ||
| Maphar | Morocco | 48.3 | ||
| Bio Atrium AG | Switzerland | 50.0 | ||